|
pubmed:abstractText |
CMV is a major clinical problem in transplant recipients. Thus, it is important to use sensitive and specific diagnostic techniques to rapidly and accurately detect CMV infection and identify patients at risk of developing CMV disease. In the present study, CMV infection after liver transplantation was monitored retrospectively by two molecular biology assays - a quantitative PCR assay and a qualitative NASBA assay. The results were compared with those obtained by prospective pp65 antigenemia determinations.
|
|
pubmed:affiliation |
Molecular Biology Unit, Microbiology Service, Hospital Geral de Santo António, R, D, Manuel II, 4099-001 Porto, Portugal. mlamorim@net.sapo.pt
|
